Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second PSMA PET scan could redefine prostate cancer treatment for nearly half of patients, per new study findings
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The scans, which detect cancer cells with high precision, appear to provide critical information that initial imaging may miss, potentially improving outcomes for those with recurrent or advanced disease. Coverage from *healthcare-in-europe.com* and *Urology Times* highlights the updated guidelines from the American Urological Association (AUA) and the Society of Urologic Oncology (SUO), which now emphasize the role of PSMA-PET in advanced prostate cancer management.
The guidelines suggest the scans should be considered for patients with biochemical recurrence or metastatic disease to refine treatment strategies. Next steps include broader adoption of PSMA-PET in clinical workflows, though coverage does not yet specify reimbursement policies or global availability.
Patient access and cost-effectiveness will likely shape implementation timelines.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (83% supported) Updated just now.
Quick answers
What percentage of prostate cancer patients may see treatment changes with a second PSMA PET scan?
Approximately 45%, according to the study cited in *Radiology Business* and *Medical Xpress*.
Which organizations updated guidelines to include PSMA-PET for prostate cancer?
The American Urological Association (AUA) and the Society of Urologic Oncology (SUO).
Is PSMA-PET widely available for prostate cancer patients?
Coverage does not yet specify global availability or reimbursement policies, though guidelines now recommend its use in specific cases.
Coverage (4)
- 2nd PET scan changes treatment for nearly half of prostate cancer patients Radiology Business · 1d ago
- Treatment change for prostate cancer: study reveals benefit of second PSMA PET healthcare-in-europe.com · 1d ago
- Updated AUA/SUO Advanced Prostate Cancer guideline emphasizes role of PSMA-PET Urology Times · 1d ago
- Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients Medical Xpress · 1d ago
Topics
Related trends
Is testosterone replacement a fix for the blahs of aging?
Regulatory shifts and medical debates reshape access to testosterone therapy amid aging population concerns
New screening tool may detect more dangerous prostate cancers than PSA testing alone
Medical reports highlight a potential shift in prostate cancer screening as new tools emerge to supplement traditional PSA testing.
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test is showing superior results in detecting aggressive prostate cancer compared to standard screening methods.
Prostate cancer blood test detects twice as many cases
A new blood test could double prostate cancer detection rates, reshaping early screening